VivoSeq
Musculoskeletal

Plantar Fasciitis

25

Pipeline Programs↗

6

Active Trials↗

15

Companies Involved↗

Plantar Fasciitis is an emerging landscape with 25 programs across 15 companies. The most active players are Fresenius Kabi Oncology Ltd., Vitae Pharmaceuticals Inc., an Allergan affiliate, Revance Therapeutics, Inc.. 6 therapies are approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

50/100

Pipeline Velocity

19/100

Mech. Concentration

33/100

Completion Rate

86/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

F

Fresenius Kabi Oncology Ltd.

1 program

Phase 1V

Vitae Pharmaceuticals Inc., an Allergan affiliate

1 program

Phase 2R

Revance Therapeutics, Inc.

4 programs

Phase 3GSK logo

GSK

2 programs

Phase 3M

Milestone Pharmaceuticals Inc.

1 program

ApprovedPfizer logo

Pfizer

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

40

clinical trials

Completed25 · 63%
Recruiting6 · 15%
Unknown status5 · 13%
Withdrawn3 · 8%
Terminated1 · 3%

Clinical Trials

Trial Activity

40 trials

Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
Recruiting·OOslo University Hospital·N/A·NCT05218785·40 enrolled
Bone Marrow Aspirate Versus Platelet-Rich Fibrin for the Treatment of Chronic Plantar Fasciitis
Recruiting·FFederal University of São Paulo·N/A·NCT07242729·72 enrolled
Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis
Recruiting·IInsel Gruppe AG, University Hospital Bern·N/A·NCT02196155·54 enrolled
Comparative Efficacy of Ice Packs Versus Cold Baths With Standard Exercise Therapy in the Management of Plantar Fasciitis
Recruiting·Ibadat International University, Islamabad·Preclinical·NCT07694999·40 enrolled
Comparative Effects of Myofascial Release and Instrument Assisted Soft Tissue Moblization in Pregnant Women With Plantar Fasciitis
Recruiting·University of Lahore·Preclinical·NCT07676058·44 enrolled
Comparison of Ultrasound-Guided Pulsed Radiofrequency and 5% Dextrose Injection in Patients With Chronic Plantar Fasciitis: A Randomized Controlled Trial
Recruiting·AAnkara City Hospital Bilkent·Preclinical·NCT07688876·50 enrolled
Platelet Rich Plasma Injection Compared With Steroid Injection for the Treatment of Plantar Fasciitis
Completed·—·N/A·NCT04985396·78 enrolled
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
Completed·RRevance Therapeutics, Inc.·Phase 2·NCT03825315·155 enrolled
Effect of Iontophoresis vs. Ultrasound and Iontophoresis in Plantar Fasciitis". Plantar Fasciitis"
Completed·UUniversity of Seville·N/A·NCT04917406·76 enrolled
Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis
Completed·WWake Forest University Health Sciences·Phase 1·NCT05868577·41 enrolled
Ultrasound-guided Pulsed Radiofrequency for Plantar Fasciitis
Completed·—·N/A·NCT02242513·36 enrolled
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
Completed·MMiMedx Group, Inc.·Phase 2/3·NCT02427191·147 enrolled
Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis
Completed·Ipsen logoIpsen·Phase 2/3·NCT00447876·40 enrolled
Efficacy of Platelet Rich Plasma in Plantar Fasciitis
Completed·UUniversity Hospital, Montpellier·N/A·NCT03857334·50 enrolled
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
Completed·RRevance Therapeutics, Inc.·Phase 2·NCT03137407·59 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)